|
 |
FDA Approval Activities for this Drug…
Infasurf (calfactant) Intratracheal Suspension, ONY NDA 20-521 7/1/1998 7/2/98 7/2/98 4/11/02 Infasurf Indication: for the prevention and treatment of Respiratory Distress Syndrome (RDS) in neonates.
For the most up-to-date approval information, please locate this API using the drug index. |
|
|